These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective. Thomas R; Kermode AR Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228 [TBL] [Abstract][Full Text] [Related]
8. Advances in therapies for neurological lysosomal storage disorders. Ellison S; Parker H; Bigger B J Inherit Metab Dis; 2023 Sep; 46(5):874-905. PubMed ID: 37078180 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Dysfunction in Lysosomal Storage Disorders. de la Mata M; Cotán D; Villanueva-Paz M; de Lavera I; Álvarez-Córdoba M; Luzón-Hidalgo R; Suárez-Rivero JM; Tiscornia G; Oropesa-Ávila M Diseases; 2016 Oct; 4(4):. PubMed ID: 28933411 [TBL] [Abstract][Full Text] [Related]
10. Human iPSC-Based Models for the Development of Therapeutics Targeting Neurodegenerative Lysosomal Storage Diseases. Luciani M; Gritti A; Meneghini V Front Mol Biosci; 2020; 7():224. PubMed ID: 33062642 [TBL] [Abstract][Full Text] [Related]
11. From bedside to cell biology: a century of history on lysosomal dysfunction. Coutinho MF; Matos L; Alves S Gene; 2015 Jan; 555(1):50-8. PubMed ID: 25275857 [TBL] [Abstract][Full Text] [Related]
12. Immune system irregularities in lysosomal storage disorders. Castaneda JA; Lim MJ; Cooper JD; Pearce DA Acta Neuropathol; 2008 Feb; 115(2):159-74. PubMed ID: 17924126 [TBL] [Abstract][Full Text] [Related]
13. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders. Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793 [TBL] [Abstract][Full Text] [Related]
14. Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency. Lotfi P; Tse DY; Di Ronza A; Seymour ML; Martano G; Cooper JD; Pereira FA; Passafaro M; Wu SM; Sardiello M Autophagy; 2018; 14(8):1419-1434. PubMed ID: 29916295 [TBL] [Abstract][Full Text] [Related]
15. Neurodegenerative Lysosomal Storage Disorders: TPC2 Comes to the Rescue! Prat Castro S; Kudrina V; Jaślan D; Böck J; Scotto Rosato A; Grimm C Cells; 2022 Sep; 11(18):. PubMed ID: 36139381 [TBL] [Abstract][Full Text] [Related]
16. Lysosomal storage disease overview. Sun A Ann Transl Med; 2018 Dec; 6(24):476. PubMed ID: 30740407 [TBL] [Abstract][Full Text] [Related]
17. TRPML1: The Ca Di Paola S; Scotto-Rosato A; Medina DL Cell Calcium; 2018 Jan; 69():112-121. PubMed ID: 28689729 [TBL] [Abstract][Full Text] [Related]
18. Hematological Findings in Lysosomal Storage Disorders: A Perspective from the Medical Laboratory. Leal AF; Nieto WG; Candelo E; Pachajoa H; Alméciga-Díaz CJ EJIFCC; 2022 Apr; 33(1):28-42. PubMed ID: 35645695 [TBL] [Abstract][Full Text] [Related]
19. Lysosomotropic Drugs: Pharmacological Tools to Study Lysosomal Function. Pisonero-Vaquero S; Medina DL Curr Drug Metab; 2017; 18(12):1147-1158. PubMed ID: 28952432 [TBL] [Abstract][Full Text] [Related]